Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-24 @ 4:02 PM
NCT ID: NCT01956266
Eligibility Criteria: Inclusion Criteria: * Experimental subjects must meet the Brain Bank criteria (Gibb \& Lees, 1988) for idiopathic PD. * All participants must: * be between the ages of 45 and 85 * have at least a sixth grade education * fluent in English * The investigators will obtain information about participant's Parkinson's disease history from medical records including: * age at onset * current age * gender * handedness * level of education * side of the body initially affected * information regarding subsequent clinical progression * medications * most recent Unified Parkinson Disease Rating Scale (UPDRS) scores * Hoehn and Yahr (H\&Y) (Hoehn \& Yahr, 1967) scores * The investigators will include subjects with H\&Y Stages between 2 and 4 * Participants must be judged as having at least a mild level of affective prosodic deficit in pretreatment testing Exclusion Criteria: * Individuals will be excluded with other forms of Parkinsonism such as: * multiple systems atrophy * Lewy body dementia * progressive supranuclear palsy * Other exclusionary criteria will be: * co-existing dementia (as indicated by score on Montreal Cognitive Assessment of below 26) * neurological disease other than idiopathic PD * major depression * any other psychiatric illness * chronic medical and neurological diseases other than PD (e.g., cardiac failure, renal disease, hepatic failure, stroke, or severe sensory deficits such as deafness or blindness (corrected visual acuity less than 20/50).
Healthy Volunteers: False
Sex: ALL
Minimum Age: 45 Years
Maximum Age: 85 Years
Study: NCT01956266
Study Brief:
Protocol Section: NCT01956266